divislab glp-1 novo nordisk relation justifies reasoning behind failed Alzheimer's trials Novo Nordisk: Intense Competition Within

GLP1 MASLD MASH treatment offers dual benefits for liver and metabolic health in people with type 2 diabetes or obesity

Kentucky Attorney General Russell Coleman is asking the United States Supreme Court to require mifepristone not be sent through the mail.

There is a growing call for policies to improve access to these potentially life-changing treatments

Clinical trials testing GLP-1 receptor agonists in patients with AD or PD have been conducted and have shown first successes, serving as proof of concept that activating GLP-1 receptor is a sensible strategy to treat AD/PD

Antioxidants like ectoin, vitamin C, and astaxanthin-rich microalgae help protect and nourish your skin